Evidence Supporting Use of PET/CT Status as a Predictor of Disease Progression in Follicular Lymphoma
In this study, patients were classified as either PET-negative or PET-positive using the 5-point Deauville criteria.
Non-Hodgkin Lymphoma
Use of Interim PET/CT to Stratify Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Patients with positive interim PET/CT demonstrated poorer overall and progression-free survival compared with patients with negative interim PET/CT.
M7-FLIPI Score Not Predictive of Outcomes in Chemo-Free Regimens for Follicular Lymphoma
Researchers did not find a significant difference in survival outcomes for high- and low-risk patients with follicular lymphoma receiving immunotherapy.
Familial Risks Associated With Hematologic Malignancies
Certain malignancies, younger age at diagnosis, and multiple affected relatives were all associated with increased familial relative risks.
Rituximab Upfront Therapy and Late Relapse Risk in Diffuse Large B-Cell Lymphoma
Fewer patients who experienced late relapse received upfront rituximab compared with patients who experienced early relapse.
Genetic Overlap Between Autoimmune Disease and NHL Not Supported by Genome-Wide Association Study
Researchers hypothesized that overlapping characteristics between autoimmune disease and NHL could be the result of similar genetic components.
Carbapenem Reduces Tumor Burden in Patients With Cutaneous T-Cell Lymphomas and Bacterial Infection
Antibiotic treatment with carbapenem for S. aureus infection was efficacious in patients with cutaneous T-cell lymphomas.
Real-World Data in the Era of Precision Medicine for Lymphoid Malignancies
The use of real-world data shows promise in guiding the development of management strategies for lymphoid malignancies.
Rituximab With or Without Lenalidomide in First-Line Treatment of Follicular Lymphoma
Results from a phase 2 trial suggest that adding lenalidomide to follicular lymphoma treatment with rituximab may be efficacious.
Concurrent Indolent Lymphomas in Diffuse Large B-Cell Lymphoma Do Not Worsen Clinical Outcomes
Patients with concurrent diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma were more likely to have germinal center B-cell-like DLBCL.
Next post in Lymphoma
